news New generation of CAR T cells developed 6 December 2019 | By Hannah Balfour (Drug Target Review) Researchers have reprogrammed CAR T cells to prevent them becoming exhausted after prolonged activity, presenting a possible new therapy for solid tumours.
news New screening method identifies potential compounds to combat cancer 4 December 2019 | By Hannah Balfour (Drug Target Review) The new screening technique may enable development of novel combination-immunotherapy regimens against cancers and persistent infections.
news microRNA could lead to new methods to treat multiple sclerosis 27 November 2019 | By Rachael Harper (Drug Target Review) In a pre-clinical model of multiple sclerosis, orally treating susceptible mice with a microRNA from the diseased gut has prevented the disease.
news Immune response against skin-living virus could prevent skin cancer 31 October 2019 | By Rachael Harper (Drug Target Review) It has been discovered that papillomaviruses induce immunity that protects patients, which could lead to a novel method for preventing skin cancer using a vaccine based on T cells.
news Protein vital for T cell formation and function revealed 29 October 2019 | By Victoria Rees (Drug Target Review) Researchers have discovered a protein that is required for T cell biological processes; they have also demonstrated the mechanism behind the protein.
news T cell immune system regulator identified by researchers 25 October 2019 | By Victoria Rees (Drug Target Review) A new study has discovered two enzymes which regulate a biological switch that controls the immune system, providing the potential to develop targeted therapies.
news Reasons why targeted immuno-oncology drugs sometimes fail discovered 24 October 2019 | By Rachael Harper (Drug Target Review) A new study has shown the specific cellular mechanisms that limit the ability of CD8 T cells to infiltrate the tumour microenvironment, which could guide new immunotherapeutic strategies in cancer.
news Global consortium formed to combat unproven cell banking services 22 October 2019 | By Victoria Rees (Drug Target Review) The International Society for Cell and Gene Therapy has created a group to tackle the rising number of commercial cell bank services that are misleading patients.
news New drug shows promise as immune therapy for cancers 17 October 2019 | By Rachael Harper (Drug Target Review) A therapy has been developed which uses a synthetic RNA molecule developed to fight viruses to trigger an immune response against tumours in mice.
news Study reveals potential of gamma delta T cells to combat breast cancer 9 October 2019 | By Victoria Rees (Drug Target Review) Researchers have discovered that a specific subset of gamma delta T cells can be found in higher numbers of breast cancer survivor tissue, indicating its role in fighting the condition.
news Research reveals calcium signalling pathway in T cells 9 October 2019 | By Victoria Rees (Drug Target Review) A study has uncovered the mechanism behind calcium entry and exit into T cells, which could be used in development of autoimmune disease treatments.
news Antibodies used to treat and reverse MS symptoms in mice 7 October 2019 | By Victoria Rees (Drug Target Review) Researchers have identified a protein on the surface of cells that cause MS and have used antibodies as an effective treatment for the condition in mice.
news T cell homing beacons for lungs identified by researchers 30 September 2019 | By Rachael Harper (Drug Target Review) Molecules that are critical for T cells to travel to and populate the lungs have been identified which could strengthen vaccines against influenza.
news Novel CAR T-cell therapy for leukaemia and lymphoma 26 September 2019 | By Drug Target Review Scientists in the US have developed a promising new CAR T-cell therapy that targets the BAFF-R protein, which has demonstrated superior cancer destruction to existing FDA-approved CAR-T therapies.
news Transplanted brain stem cells survive without anti-rejection drugs in mice 17 September 2019 | By Rachael Harper (Drug Target Review) An experiment with mice has successively blocked the immune system's T cells from killing transplanted cells.
